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ABSTRACT 
Objective: This experiment aims to investigate the hepatotherapeutic effect of Aloe vera (AV), Azadirachta indica (N), and Moringa oleifera (MO). 
Methods: Eighty albino rats have been divided into ten groups. The first group was fed on a basal diet while the second group was administered 
paraffin (10 ml/kg body weight) through gavage for four days. The third to the tenth groups received (5 ml/kg body weight) CCl4: liquid paraffin 
(2:1) for three days followed by (10 ml/kg body weight) CCl4: liquid paraffin (2:1) for one day through gavage. Group three kept without any 
treatment, other groups then received (AV) (60 mg/kg body weight), (MO) (200 mg/kg body weight), (N) (200 mg/kg body weight), bi-extract of 
(AV+N), bi-extracts of (AV+MO), bi-extract of (MO+N), and tri-extracts of (AV+N+MO) respectively for 36 d. The liver and blood were studied for 
hepatotoxicity and antioxidant indices. 
Results: Biochemical and histopathological analysis revealed that CCl4 elevated plasma liver enzymes (aspartate transaminase, alanine 
aminotransferase, and gamma glutamyl transferase). Carbon tetrachloride also caused an elevation in erythrocyte content of glutathione with a 
concomitant increase in the plasma malondialdehyde content, along with marked atrophy of hepatocytes. However, these effects were ameliorated 
by the treatment of rats with the different extracts. 
Conclusion: Results showed that administration of the aquatic extracts of Aloe vera, Neem, and Moringa (separately/mixedly) played a therapeutic 
role against CCl4-induced liver damage by improving liver enzyme activities, antioxidant blood parameters, and a liver histopathological picture of 
intoxicated rats. 
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INTRODUCTION 
The liver is responsible for the metabolism and detoxification of the 
most components that enter the body. Carbon tetrachloride (CCl4) 
has been extensively used to study hepatotoxicity in animal models 
by initiating lipid peroxidation thereby injurious to kidney, heart, 
testis, and brain, in addition to liver pathogenesis [1-5]. It is a potent 
lipid-toxin that has been reported to induce acute and chronic 
tissue injuries [6,7] through bioactivation of the phase І 
cytochrome p450 system to form reactive metabolic 
trichloromethyl radicals (.OOCCl3). These free radicals can 
covalently bind to macromolecules such as proteins, lipids, and 
nucleic acids. The double allylic hydrogen bonds of unsaturated fatty 
acid (PUFA) are susceptible to abstraction by free radicals. CCl4 
exposure induced increasing in lipo peroxide and free peroxide 
radial concentrations, which are highly reactive and cause injury or 
necrosis [8, 9].  
At the molecular level, CCl4 activates tumor necrosis factor-alpha 
(TNF-α), nitric oxide (NO), transforming growth factors alpha (TGF-α), 
transforming growth factor–beta (TGF-β), and processes that appear 
to direct the cell primarily toward (self-) destruction or fibrosis. TNF-α 
pushes toward apoptosis whereas the TGFs appear to direct toward 
fibrosis. Interleukin (IL)-6, although induced by TNF-α, has a clearly 
antiapoptotic effect and IL-10 also counteracts TNF-α action. Thus, 
both interleukins have the potential to initiate recovery of the CCl4-
damaged hepatocyte. Several of the above-mentioned toxication 
processes can be specifically interrupted with the use of antioxidants 
and mitogens [8]. Natural antioxidants could prevent the deleterious 
effects of toxic agents by scavenging free radicals and other reactive 
oxygen species or by modulating the inflammatory response [10, 11]. 
Therefore, the use of antioxidants in pharmacology is extensively 
studied as a treatment for many diseases.  
Phenolic compounds are commonly found in both edible and other 
traditional medicinal plants; they have been reported to have 
multiple biological activities including free radical scavenging 
activity [12]. Typical phenolics that possess antioxidant activity are 
mainly phenolic acids and flavonoids, which commonly accumulate 
in the epidermal cells of plant organs such as flowers, leaves, stems, 
roots, seeds and fruits being found in glycosidic form (glycosides) 
and non-glucosidic form [13]. Moringa oleifera Lam is the most 
widely distributed species of the Moringaceae family throughout the 
World especially in Asia. It has a remarkable range of 
pharmacological properties in addition to significant nutritional 
value [14]. Various plant parts have wide medicinal applicability for 
the treatment of cardiovascular diseases since it contains nitrile, 
mustard oil glycosides, and thiocarbamate glycosides. These 
important bioactive constituents are thought to be responsible for 
their diuretic, cholesterol lowering, and antiulcer properties [15].  
Authors in [16] showed the strong antioxidant properties of MO 
edible parts in vitro. This antioxidant activity of MO extracts is due to 
the presence of various bioactive compounds such as chlorogenic 
acid, rutin, quercetin glucoside, and kaempferol rhamnoglucoside. 
Furthermore, the extract of Moringa leaves and other parts have 
been shown to have potent antioxidant action in vivo [17-20]. 
Various studies in male rats have demonstrated the 
hepatoprotective effects of different MO edible part extracts against 
hepatotoxin-induced acute liver damage [21, 22]. Also, Azadirachta 
indica (Family: Meliaceae) is well known for its various medicinal 
properties. Different parts of the plant like bark, young fruit, seeds 
and flowers have been studied for their pharmacological actions, 
where the leaves of this plant have been found to possess various 
pharmacological properties [23]. Yet, the Aloe vera contains 
anthraquinone glycosides, polysaccharides, aloeresin, glucomannan 
and β-sitosterol [24-25]. Antioxidative phenolic was recently 
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isolated from Aloe barbadensis and identified as aloeresin 
derivatives [26-27]. 
The present study was accordingly designed to investigate the 
potential of the extract of Moringa oleifera edible parts, Azadirachta 
indica (Neem) leaves and Aloe vera gel against CCl4 induced 
hepatotoxicity in rats by assaying biochemical and histopathology of 
liver tissues. 
MATERIALS AND METHODS 
Plant materials 
Fresh specimens of Aloe vera (L.) BURM. Fil. were collected from the 
greenhouse of the National Research Center in Egypt. Fresh leaves of 
this plant were used in this study. Aloe vera leaves were weighed, 
washed, and cut in the middle then the gel was separated by 
scratching with a spoon. The gel (400g = 2.5g dried matter) [28] was 
homogenized in a blender then diluted with an equal volume of 
distilled water and homogenized for the second time. This stock was 
kept at 4 °C and used to prepare AV extract (60 mg/kg body weight). 
Shaded dried leaves of Moringa oleifera were collected from the 
greenhouse of the Agricultural Research Center in Egypt. 500 gm of 
dried grounded leaves of Moringa added with 6liters of tap water 
and boiled then the residual sieved by mesh sieve. Aqueous Moringa 
stock (2400 ml) kept at 4 °C and used to prepare MO extract (200 
mg/kg body weight). 
Sun dried leaves of Azadirachta indica were collected from the 
nursery of the Ministry of Agricultural and Land Reclamation in 
Egypt. 350 gm of dried grounded leaves of Neem added with 5liters 
of tap water and boiled then the residual sieved by mesh sieve. 
Aqueous Neem stock (1450 ml) kept at 4 °C and used to prepare N 
extracts (200 mg/kg body weight). 
Animals and treatment [29, 30] 
Eighty male albino rats weighing (100-120g) were provided by the 
animal house of the National cancer Institute in Egypt. The rats were 
kept in ordinary cages at room temperature of 25±4 °C with a 12 h 
dark/light cycles. They had free access to standard laboratory feed 
and water according to the study protocol. After acclimation, the rats 
were randomly divided into ten groups of eight animals each. The 
animal ethics committee, Ain Shams University, Cairo, Egypt, 
approved the study protocol. 
Group 1: Served as normal healthy control, was fed basal diet and 
tap water. 
Group 2: Received paraffin (10 ml/kg body weight) through gavage 
for four days and tap water. 
Group 3: Disease control-Treated with Carbon tetrachloride for four 
days. 
Group 4: Diseased animals received Aloe vera extract (AV) (60 
mg/kg body weight) as the drinking water. 
Group 5: Diseased animals received Moringa oleifera extract (MO) 
(200 mg leaves extract/kg body weight) as the drinking water. 
Group 6: Diseased animals received Azadirachta indica (N) (200 mg 
leaves extract/kg body weight) as the drinking water. 
Group 7: Diseased animals received the extracts of (AV+N) in equal 
volumes (1:1) as the drinking water. 
Group 8: Diseased animals received the extracts of (AV+MO) in equal 
volumes (1:1) as the drinking water. 
Group 9: Diseased animals received the extracts of (MO+N) in equal 
volumes (1:1) as the drinking water. 
Group 10: Diseased animals received the extracts of (AV+N+MO) in 
equal volumes (1:1:1) as the drinking water. 
Carbon tetrachloride diluted with paraffin CCl4: liquid paraffin (2:1) 
was administered in a dose of (5 ml/kg body weight) for 3 d 
followed by (10 ml/kg body weight) CCl4: liquid paraffin (2:1) for 
one day through gavage to all animal groups except for control 
animals in groups 1 and 2. Animals of the diseased group received 
only CCl4, to assist assessing the severity of toxicity produced by 
carbon tetrachloride administration. Diseased animals from the 
treated groups received different mixtures of aqueous extracts as 
the drinking water for 36 d. Four rats from each group were 
weighed then killed by cutting the jugular vein after 18 and 36 d of 
treatments to evaluate the treatment effect of each extract during 
this period. The blood was collected while the liver was removed. 
Liver samples for the histological examination were kept at 10% 
formaldehyde and those for analytical procedure kept at-4 °C. 
Biochemical investigations 
Blood samples have been taken from the jugular vein. Heparin was 
used as an anticoagulant. 
Peripheral blood processing 
The collected blood was centrifuged at 4000 rpm for 15 min and 
plasma was separated. 
Erythrocyte processing 
The erythrocyte pellet was washed thrice with saline, and the cell 
suspension was diluted with 4 times its volume ice-cold distilled 
water. Then it was centrifuged at 4000 rpm for 15 min. Finally, the 
supernatant (erythrocyte lysate) was separated. 
Liver samples processing 
Liver samples were fixed in 10% phosphate-buffered formalin, and 
paraffin sections (3–5 mm) were prepared. Liver sections were used 
for hematoxylin and eosin (HE) staining. The sections were 
examined using a light microscope Olympus, CX31, Tokyo, Japan. 
Assessment of hepatotoxicity 
In order to estimate hepatotoxicity, plasma aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), albumin, total protein and 
gamma glutamyl transferase (GGT) were evaluated using commercially 
available kits. Moreover, Histopathologic examination of liver tissue was 
done to assess the degree of congestion, vacuolar degeneration of 
hepatocytes and hepatocyte atrophy. 
Assessment of oxidative stress 
For determination of oxidative stress, plasma lipid peroxide 
malondialdehyde (MDA) was determined, and reduced glutathione 




Administration of CCl4 markedly increased the activity of liver marker 
enzymes such as AST, ALT, and GGT as compared with the control 
group (p<0.001). In addition, it increased (p<0.01) total protein 
content but no significant difference on albumin. Elevation in the 
secretion of these enzymes was potentially decreased by 18 d of 
treatment with mono, bi, and tri aqueous extracts of Aloe vera (AV), 
Azadirachta indica (N), and Moringa oleifera (MO) (table 1). Prolonged 
treatment for 36 d significantly restored them to normal (table 2). 
CCl4 treatment in rats significantly increased (p<0.001) plasma lipid 
peroxide malondialdehyde (MDA) content while decreased the 
activity of (p<0.05) reduced glutathione GSH in the erythrocyte 
lysate. These alterations were remarkably attenuated by 
administration of separately/mixedly Aloe vera (AV), Azadirachta 
indica (N) and Moringa oleifera (MO) aqueous extracts after 18 and 
36 d (table 3 and 4). 
Histopathological evaluation (table 5) 
Liver sections from the control groups 1 and 2 showed normal liver 
histology with no atrophy of hepatocytes or congestion (fig. 1. A and 
B). CCl4 treated control animals at group 3 showed marked atrophy 
of hepatocytes around central veins and vacuolar degeneration of 
the rest of hepatocytes with inflammation of the portal tract (fig. 1. 
C). Sections examined of the animals treated with (AV) group 4 for 
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18 d revealed a congested central vein and vacuolar degeneration of 
hepatocytes in the centrilobular zone while those treated for 36 d 
revealed mild congestion of central veins without atrophy or 
degeneration of hepatocytes (fig. 1. D and E). 
 
Table 1: Effect of aqueous extracts on biochemical parameters after 18 d of treatment 
Group  Extract AST (IU/l) ALT (IU/l) GGT (IU/l) Albumin (g/dl) Total protein (g/dl) 
Normal - 35.8±2.6 17.28±1.5 1474±407 3.4±0.2 4.9±1.1 
Paraffin - 36.7±8.4 18.7±3 1713.8±72 3.6±0.1 5.7±1.1 
CCl4 - 90±12.4*** 52.3±1.8*** 1933.3±32*** 3.5±0.3 6.21±0.6** 
Group 4 AV 44.9±4*** 17.28±1.5*** 1882.9±18*** 3.2±0.2 5.2±0.1*** 
Group 5 MO 46±2*** 21.1±2.5*** 1914.2±17 3.7±0.1 5.2±0.2*** 
Group 6 N 47±1.4*** 14.2±2*** 2038.4±210 4.7±0.3 5.9±0.1 
Group 7 AV+N 80±20.4* 16.32±3.4*** 1937.7±34.8 3.7±0.7 5.4±0.4** 
Group 8 AV+MO 98.5±13.4 20.2±10*** 1889.9±19** 3±0.7 4.55±0.5*** 
Group 9 MO+N 81±4.3 35.5±9.5*** 1907.8±9.3* 3.5±0.2 4.8±0.14*** 
 Group 10 AV+N+MO 75.3±16.5** 20.4±3.7*** 1934.5±14 3.25±0.4 4.75±0.5*** 
AV: mono-aqueous extracts of Aloe vera, MO: mono-aqueous extract of Moringa, N: mono-aqueous extract of Neem, AV+N: bi-aqueous extract of Aloe 
vera and Neem, AV+MO: bi-aqueous extract of Aloe vera and Moringa, MO+N: bi-aqueous extract of Moringa and Neem, and AV+N+MO: tri-aqueous 
extract of Aloe vera, Neem and Moringa, Values are expressed as mean±SD (n=4), p*<0.05, p**<0.01, and p***<0.001 
 
Table 2: Effect of aqueous extracts on biochemical parameters after 36 d of treatment 
Group  Extract AST (IU/l) ALT (IU/l) GGT (IU/l) Albumin (g/dl) Total protein (g/dl) 
Normal - 35.8±2.6 17.28±1.5 1474±407 3.4±0.2 4.9±1.1 
Paraffin - 36.7±8.4 18.7±3.3 1713.8±72 3.6±0.1 5.7±1.1 
CCl4 - 90±12.4*** 52.3±1.8*** 1933±31.9*** 3.5±0.3 6.2±0.6** 
Group 4 AV 35±0.5*** 34.6±2.7*** 1395±72*** 3.5±0.1 6±0.4 
Group 5 MO 38±0.2*** 29.3±12*** 1364±30*** 2.9±0.5 5.6±1 
Group 6 N 35±0.2*** 31.2±2.7*** 1426±82*** 2.6±0.4 5.4±0.6** 
Group 7 AV+N 49.5±6.3*** 29.7±7*** 1366±27*** 3.4±0.4 6±0.3 
Group 8 AV+MO 52.3±0.7*** 31.7±2*** 1382±60*** 2.6±0.3 5.6±0.1 
Group 9 MO+N 58±0.4*** 41.8±1*** 1391±10*** 2.6±0.1 5.3±0.1** 
Group 10 AV+N+MO 58±0.2*** 35.3±5*** 1390±5*** 2.5±0.1 6±0.3 
AV: mono-aqueous extracts of Aloe vera, MO: mono-aqueous extract of Moringa, N: mono-aqueous extract of Neem, AV+N: bi-aqueous extract of Aloe 
vera and Neem, AV+MO: bi-aqueous extract of Aloe vera and Moringa, MO+N: bi-aqueous extract of Moringa and Neem, and AV+N+MO: tri-aqueous 
extract of Aloe vera, Neem and Moringa, Values are expressed as mean±SD (n=4), p*<0.05, p**<0.01, andp***<0.001 
 
Table 3: Effect of aqueous extracts on plasma MDA content and erythrocyte GSH content after 18 d of treatment 
Group  Extract MDA nmol/ml GSH mg/dl 
Normal - 3.5±2 3.25±2 
Paraffin - 3.6±2 3.6±2 
 CCl4 - 11.23±3*** 1.5±0.9* 
Group 4 AV 2.8±1*** 5.7±1.3*** 
Group 5 MO 4.4±0.7*** 8.6±0*** 
Group 6 N 6.7±0.5*** 8.6±3.8*** 
Group 7 AV+N 4±0.5*** 7.7±0.7*** 
Group 8 AV+MO 4±1*** 8.5±3.2*** 
Group 9 MO+N 3.5±1.5*** 7.1±2.7*** 
Group AV+N+MO 2.9±2*** 5.8±0.4*** 
AV: mono-aqueous extracts of Aloe vera, MO: mono-aqueous extract of Moringa, N: mono-aqueous extract of Neem, AV+N: bi-aqueous extract of Aloe 
vera and Neem, AV+MO: bi-aqueous extract of Aloe vera and Moringa, MO+N: bi-aqueous extract of Moringa and Neem, and AV+N+MO: tri-aqueous 
extract of Aloe vera, Neem and Moringa, Values are expressed as mean±SD (n=4), p*<0.05, p**<0.01, and p***<0.001 
 
Table 4: Effect of aqueous extracts on plasma MDA content and erythrocyte GSH content after 36 d of treatment 
Group Extract MDA  nmol/ml GSH mg/dl 
Normal - 3.5±2 3.25±2 
Paraffin - 3.6±2 3.6±2 
CCl4 - 11.2±2.5*** 1.5±0.9* 
Group 4 AV 3.8±2*** 6.8±1.6*** 
Group 5 MO 2.1±0.4*** 5.4±0.3*** 
Group 6 N 3.1±0.3*** 5.85±0.6*** 
Group 7 AV+N 1.8±0.4*** 5±0.8*** 
Group 8 AV+MO 1.8±1*** 5.9±1.8*** 
Group 9 MO+N 1.7±0.5*** 5.5±0.4*** 
Group 10 AV+N+MO 2.3±0.7*** 4.5±0.5*** 
 AV: mono-aqueous extracts of Aloe vera, MO: mono-aqueous extract of Moringa, N: mono-aqueous extract of Neem, AV+N: bi-aqueous extract of Aloe 
vera and Neem, AV+MO: bi-aqueous extract of Aloe vera and Moringa, MO+N: bi-aqueous extract of Moringa and Neem, and AV+N+MO: tri-aqueous 
extract of Aloe vera, Neem and Moringa, Values are expressed as mean±SD (n=4), p*<0.05, p**<0.01, and p***<0.001  
Mohamed et al. 




Fig. 1: Hepatic histology of rats (light microscope, × 400), A: normal control, B: paraffin control, C: CCl4 control, D: treated with Aloe vera 
for 18 d, and E: treated with AV for 36 d 
 
 
Fig. 2: Hepatic histology of rats (light microscope, × 400), A: treated with Moringa for 18 d, B: treated with Moringa for 36 d, C: treated 
with Neem for 18 d, D: treated with Neem for 36 d, E: treated with Aloe vera and Neem for 18 d, and F: treated with Aloe vera and Neem 
for 36 d 
 
 
Fig. 3: Hepatic histology of rats (light microscope, × 400), A: treated with Aloe vera and Moringa for 18 d, B: treated with Aloe vera and 
Moringa for 36 d, C: treated with Moringa and Neem for 18 d, D: treated with Moringa and Neem for 36 d, E: treated with Aloe vera, Neem 
and Moringa for 18 d, and F: treated with Aloe vera, Neem and Moringa for 36 d 
 
The sections of animals treated with (MO) group 5 for 18 d showed 
congestion of central vein and sinusoids of centrilobular zone with 
no degeneration or atrophy of hepatocytes and those treated for 36 
d showed normal liver like control with preserved liver architecture, 
without congestion, vacuolar degeneration, or atrophy of 
hepatocytes (fig. 2. A and B). Liver sections from the animals treated 
with (N) group 6 for 18 d showed marked congestion of 
centrilobular zone with consequent pressure atrophy of 
hepatocytes, and vacuolar degeneration of hepatocytes in mid zone 
and periportal zone whereas those treated for 36 d showed 
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improvement of congestion and atrophy with remaining vacuolar 
degeneration of hepatocytes (fig. 2. C and D). Sections of animals 
treated with (AV+N) group 7 for 18 d and 36 d showed same 
histopathologic features as in group 6 (fig. 2. E and F). Animals sections 
treated with (AV+MO) group, 8 for 18 d, showed congestion of central 
veins and centrilobular zones with mild mid zonal vacuolar degeneration 
of hepatocytes while extended treatment for 36 d showed improvement 
of congestion and vacuolar degeneration (fig. 3. A and B). Animals 
sections treated with (MO+N) group, 9 for 18 d, showed marked 
vacuolar degeneration while extended treatment for 36 d showed 
restoration of normal liver histology with the disappearance of vacuolar 
degeneration (fig. 3. C and D). Sections of animals treated with 
(AV+N+MO) group 10 for 18 d showed marked congestion and pressure 
atrophy of centrilobular and mid zonal hepatocytes and vacuolar 
degeneration at the periphery while extended treatment for 36 d 
revealed complete restoration of normal liver histology (fig. 3. E and F). 
 
Table 5: Histopathological evaluation of liver after 18 and 36 d of treatment 
Group Extract Congestion of central vein and 
sinusoids 
Vacuolar degeneration of 
hepatocytes 
Pressure atrophy of 
hepatocytes 
After 18 d After 36 d After 18 d After 36 d After 18 d After 36 d 
 Normal - - - - - - - 
 Paraffin - - - - - - - 
 CCl4 - + + + + + + 
Group 4 AV + + + _ _ _ 
Group 5 MO + _ _ _ _ _ 
 Group 6 N + _ + + + _ 
Group 7 AV+N + _ + + + _ 
Group 8 AV+MO + _ _ _ _ _ 
Group 9 MO+N _ _ + _ _ _ 
Group 
10 
AV+N+MO + _ + _ + _ 
 AV: mono-aqueous extracts of Aloe vera, MO: mono-aqueous extract of Moringa, N: mono-aqueous extract of Neem, AV and N: bi-aqueous extract of 
Aloe vera and Neem, AV and MO: bi-aqueous extract of Aloe vera and Moringa, MO and N: bi-aqueous extract of Moringa and Neem, and AV, N and 
MO: tri-aqueous extract of Aloe vera, Neem and Moringa 
 
DISCUSSION 
Liver disorders were expressed in several forms i.e. Jaundice, acute 
and chronic hepatitis, hepatotoxicity, and degenerative disorders 
resulting in fibrosis of the liver are still without appropriate 
therapies. Many chemicals and drugs can injure the liver [31]. Wide 
varieties of herbal formulations are in use to counter the 
hepatotoxicity due to such insults. Drugs from the herbal origin are 
the only treatment available for liver damage. However, there has 
always been a need for more studies that can provide a clear picture 
for the prolonged effect of these herbs, and better agents that can 
provide faster recovery. In the present study, the mono-aqueous 
extracts of Aloe vera (AV), Azadirachta indica (N), and Moringa 
oleifera (MO), bi-aqueous extracts of AV+N, AV+MO and MO+N, and 
tri-aqueous extract AV+N+MO were investigated for hepato-
therapeutic activity against liver damage caused by CCl4. Each plant 
has demonstrated liver-protecting potentials but has not been 
combined in any study. Carbon tetrachloride is commonly used the 
toxin to induce liver damage in experimental studies. 
CCl4 administration significantly elevated (p<0.001) the plasma 
levels of AST, ALT and GGT although it moderately (p<0.01) 
increased the total protein content while had no significant effect on 
albumin (table. 1 and 2). CCl4 causes chronic hepatocyte injuries, as 
well as alters membrane integrity, which cause hepatic enzymes, 
leak out [32]. After 18 d of aqueous extracts AST level was 
significantly (p<0.001) decreased by mono aqueous extracts of Aloe 
vera, mono aqueous extract of Moringa, and mono aqueous extract 
of Neem but less with the tri-aqueous extract Aloe vera, Neem, and 
Moringa (p<0.01) and bi aqueous extract of Aloe vera and Neem 
(p<0.05). While it significantly (p<0.001) restored to normal after 36 
d of treatment with the mono, bi, and tri aqueous extracts of Aloe 
vera, Neem, and Moringa. On the other hand, ALT was significantly 
(p<0.001) decreased after 18 d of treatment by all mono, bi, and tri-
aqueous extracts of Aloe vera, Neem, and Moringa.  
Moreover, after 18 d of treatment GGT level was significantly 
decreased by Aloe vera mono aqueous extract and less with Aloe 
vera and Moringa bi aqueous extract (p<0.01) and Moringa and 
Neem bi aqueous extract (p<0.05). However, after 36 d of treatment, 
it was significantly (p<0.001) restored to the normal level by all 
mono, bi, and tri-aqueous extracts of Aloe vera, Neem, and Moringa. 
It is noted that group 6 treated with Neem mono aqueous extract 
has the least effect on lowering GGT assuming that Azadirachta 
indica (N) had a minimum protective effect against liver cell damage. 
These results indicate that Aloe vera, Neem, and Moringa had the 
ability to treat CCl4 hepatotoxicity, which is in agreement with 
previous studies [33-35] that reports their protective consequence 
against CCl4 induced hepatotoxicity. 
Malondialdehyde (MDA) is one of the products of polyunsaturated 
fatty acid peroxidation and is a good indicator of the degree of lipid 
peroxidation [36], which is related to CCl4 induced tissue damage. In 
the present study (Table. 3 and 4), the significant increase (p<0.001) 
in the plasma MDA level of CCl4- intoxicated rats was significantly 
reduced (p<0.001) by treatment with the mono-aqueous extracts of 
Aloe vera (AV), Azadirachta indica (N) and Moringa oleifera (MO); bi-
aqueous extracts of AV+N, AV+MO and MO+N, and tri-aqueous 
extract AV+N+MO after 18 d indicating their ability to break the 
chain reaction of lipid peroxidation. 
According to these results, we may assume that the therapeutic 
potential of these different aqueous extracts is dependent on an 
antioxidant mechanism. These results concluded that Aloe Vera, 
Neem, and Moringa extracts effectively inhibit CCl4-induced tissue 
damage due to the presence of various antioxidant bioactive 
compounds. They also are in line with previous studies [33,37,38] 
investigating the hepatoprotective nature of these plants. 
Glutathione is an important non-enzymatic antioxidant that protects 
the cell. This study showed that administration of CCl4 caused 
depletion (p<0.05) of GSH level observed in erythrocytes lysate 
which can be an important factor in the CCl4 induced toxicity. The 
level of GSH was significantly restored (p<0.001) following the 
treatment with the mono-aqueous extracts of Aloe vera, Neem, and 
Moringa, bi-aqueous extracts of AV+N, AV+MO and MO+N, and tri-
aqueous extract AV+N+MO. The mechanism of the therapeutic 
action of these extracts against CCl4 toxicity might be due to 
restoration of GSH level and presence of bioactive compounds. 
These results are in agreement with previous findings [33,35,38] on 
the hepatoprotective nature of these plants. 
Regarding histopathological results (table. 5), various 
histopathologic changes in the form of congestion, vacuolar 
degeneration, and pressure atrophy of hepatocytes are seen due to 
CCl4 administration. 
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Group 4 (administered Aloe vera mono aqueous extract) showed a 
protective effect against hepatocyte atrophy and vacuolar 
degeneration when the treatment was extended from 18 to 36 d 
indicating that AV aqueous has a protective effect on hepatocyte 
integrity. It is noted that vacuolar degeneration is present in group 4 
(AV) treated for 18 d while it is absent in groups 5 (administered 
Moringa mono aqueous extract) and 8 (administered the bi-aqueous 
extract AV+MO) treated for 18 d indicating that MO is more 
powerful than AV for improving liver cell injury. 
In the liver section of groups administered Neem mono aqueous 
extract and bi-aqueous extract of AV+N, there was marked 
congestion with consequent pressure atrophy of hepatocytes and 
marked vacuolar degeneration at the peripheral zone after 18 d of 
treatment. Congestion and hepatocyte atrophy were relieved when 
the treatment was extended for 36 d. However, there was still 
vacuolar degeneration of hepatocytes. These results indicate that 
Neem had the least protective effect on liver cell injury in 
comparison to other groups where there was no hepatocyte atrophy 
and vacuolar degeneration that has been improved when treatment 
was extended for 36 d. These results are consistent with biochemical 
results, concluded that group 6 (N) has the least effect on GGT 
assuming that Azadirachta indica (N) had the minimum protective 
effect against liver cell damage. 
In all groups, there was an improvement in the histopathologic 
features of liver cell injury (table 5) when the treatment was 
extended for 18 to 36 d except group 6 and 7 (where there was no 
improvement of vacuolar degeneration with long-term treatment). 
This observation is consistent with biochemical results indicating that 
liver enzymes are elevated in rats treated for 18 d then lowered in rats 
treated for 36 d. 
CONCLUSION 
In the present study, the aquatic extracts of Aloe vera, Azadirachta 
indica, and Moringa oleifera separately/mixedly ameliorated the 
hepatotoxic effect of carbon tetrachloride and restored the 
antioxidant status after 36 d of treatment. Administration of extracts 
orally substantially restored liver enzymes, erythrocyte glutathione 
content, and plasma malondialdehyde to the normal level along with 
the improvement of the histopathological features of the injured 
liver cells. Treatment with Moringa mono extract, Aloe vera mono 
extract, (Aloe vera and Moringa) bi extract, (Moringa and Neem) bi 
extract, Neem mono extract, (Aloe vera and neem) bi extract, and 
(Aloe vera, Moringa, and Neem) tri extract for 36 d were more 
effective in restoring liver enzymes and improving the 
histopathological features of liver cells than the 18 d duration. The 
Neem mono extract and the (Aloe vera and Neem) bi extract had the 
least protective effect on hepatotoxicity as they relieved the 
congestion and hepatocyte atrophy. However, there was still 
vacuolar degeneration of hepatocytes after 36 d of treatment, which 
could be enhanced if the treatment is extended than 36 d. These 
results emphasize that administration of Aloe vera gel, Moringa and 
Neem leaves aquatic extracts could protect against carbon 
tetrachloride-induced hepatotoxicity. Further studies are 
recommended to decrease the treatment duration by increasing the 
concentration of the used extracts and investigate any side effects.  
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